| Literature DB >> 30300142 |
Babita Madan1, Nathan Harmston1,2, Gahyathiri Nallan1, Alex Montoya3, Peter Faull3, Enrico Petretto2,3, David M Virshup1,4.
Abstract
Activating mutations in the Wnt pathway drive a variety of cancers, but the specific targets and pathways activated by Wnt ligands are not fully understood. To bridge this knowledge gap, we performed a comprehensive time-course analysis of Wnt-dependent signaling pathways in an orthotopic model of Wnt-addicted pancreatic cancer, using a porcupine (PORCN) inhibitor currently in clinical trials, and validated key results in additional Wnt-addicted models. The temporal analysis of the drug-perturbed transcriptome demonstrated direct and indirect regulation of more than 3,500 Wnt-activated genes (23% of the transcriptome). Regulation was both via Wnt/β-catenin and through the modulation of protein abundance of important transcription factors, including MYC, via Wnt-dependent stabilization of proteins (Wnt/STOP). Our study identifies a central role of Wnt/β-catenin and Wnt/STOP signaling in controlling ribosome biogenesis, a key driver of cancer proliferation.Entities:
Keywords: Cancer; Cell Biology; Mouse models; Oncogenes; Oncology
Mesh:
Substances:
Year: 2018 PMID: 30300142 PMCID: PMC6264740 DOI: 10.1172/JCI122383
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808